« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 51, Issue 3
, Pages 628-635
, 1 November 2001
The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial
References
-
.
External beam radiation treatment for prostate cancer (Still the gold standard).
Oncology. 1992;6:79–86
-
Smalley SR, Evans RG. Radiation morbidity to the gastrointestinal tract and liver. In: Plowman P, McElwain T, Meadows A, editors. Complications of cancer management. Oxford, England: Butterworth Heinemann; 1991. Chapt. 18:276–279.
- A phase III double blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis. Radiother Oncol. 1997;45:117–123
- . Treatment of chronic radiation enteritis with sulphasalazine and systemic corticosteroids. Am J Gastroenterol. 1976;65:201–208
- The relationship between early and late gastrointestinal complications of radiation therapy for stage 1B carcinoma of the cervix. Cancer. 1987;60:2195–2200
- . Sucralfate. Non ulcer uses. Am J Gastroenterol. 1995;80:206–209
- . Sucralfate. N Engl J Med. 1991;325:1017–1025
-
Role of vascular factors including angiogenesis in the mechanism of action of sucralfate.
Am J Med. 1991;91:158–160
- . Pathways of gastrointestinal protection and repair (Mechanism of action of sucralfate). Am J Med. 1989;86:23–31
- Does sucralfate affect the normal gastric mucosa? Histologic, ultrastructural, and functional assessment in the rat. Gastroenterology. 1986;90:893–905
- . Sucralfate induces proliferation of dermal fibroblasts and keratinocytes in culture and granulation tissue formation in full thickness skin wounds. Agents Actions. 1991;34:229–231
-
.
Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer.
J Clin Oncol. 1992;10:969–975
- Efficacy of sucralfate in the prophylaxis of diarrhoea secondary to acute radiation-induced enteritis. Preliminary results of a double blind randomised trial. Med Clin (Barc). 1991;96:449–452
-
Sucralfate in the prevention of treatment induced diarrhea in patients receiving pelvic radiation therapy (A North Central Cancer Treatment Group phase III double-blind placebo controlled trial).
J Clin Oncol. 2000;18:1239–1245
-
.
Blinding during data analysis and writing of manuscripts.
Controlled Clin Trials. 1996;17:285–293
- . A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988;75:800–802
- . Oral sucralfate in acute radiation oesophagitis. Acta Oncol. 1994;33:61–63
- Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy. A randomised, double-blind crossover study. Acta Oncol. 1990;29:171–173
- . Skin protection by sucralfate cream during electron beam therapy. Acta Oncol. 1994;33:201–203
- . The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy. Int J Radiat Oncol Biol Phys. 1994;28:693–698
- Sucralfate mouth washing in the prevention of radiation-induced mucositis (A placebo-controlled, double-blind randomised study). Int J Radiat Oncol Biol Phys. 1994;30:177–182
- Sucralfate for radiation mucositis (Results of a double blind randomised trial). Int J Radiat Oncol Biol Phys. 1997;37:275–279
-
Sucralfate cream in the management of moist desquamation during radiotherapy.
Australasian Radiol. 1997;41:270–275
-
Elsaid A, Elassal S. Sucralfate with pelvic radiotherapy: Sense or nonsense? Abstract 2112; Proceedings of the 40th Annual ASTRO Meeting; 1998.
- Does sucralfate reduce the acute side effects in head and neck cancer treated with radiotherapy? A double blind randomized trial. Radiother Oncol. 1998;47:149–153
- Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci. 1991;36:103–107
- Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double blind placebo controlled study. Acta Oncol. 1995;34:219–223
☆ This study was supported in part by a grant from Chugai Pharmaceuticals, as well as from the Radiation Oncology trust fund from the Prince of Wales Hospital. The investigators maintained complete scientific independence of the trial with respect to its design, conduct, analysis, interpretation, and publication.
PII: S0360-3016(01)01660-1
doi: 10.1016/S0360-3016(01)01660-1
© 2001 Elsevier Science Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 51, Issue 3
, Pages 628-635
, 1 November 2001
